Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: Study Protocol.

被引：0
|
作者：
Calais, Jeremie [1 ]
Zhu, Shaojun [1 ]
Hrimas, Nader [2 ]
Eiber, Matthias [3 ]
Hadaschik, Boris [2 ]
Stuschke, Martin [2 ]
Herrmann, Ken [2 ]
Czernin, Johannes [1 ]
Kishan, Amar U. [1 ]
Nickols, Nicholas G. [1 ]
Elashoff, David [1 ]
Fendler, Wolfgang [2 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Univ Essen Gesamthsch, Essen, Germany
[3] TUM, Munich, Germany
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT257
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for the detection of low- and intermediate-risk prostate cancer
    Chuanchi Zhou
    Yongxiang Tang
    Zhihe Deng
    Jinhui Yang
    Ming Zhou
    Long Wang
    Shuo Hu
    EJNMMI Research, 12
  • [42] 68Ga-PSMA PET/CT in Preoperative Staging of Intermediate and High Risk Prostate Cancer Patients
    Schiller, C.
    Beheshti, M.
    Geinitz, H.
    Aschacher, B.
    Moinfar, F.
    Broinger, G.
    Pallwein-Prettner, L.
    Loidl, W.
    Langsteger, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S167 - S167
  • [43] THE IMPACT OF 68GA-PSMA PET/CT ON THERAPY MANAGEMENT OF HIGH RISK PROSTATE CANCER
    Simsek, Duygu Has
    Isik, Emine Goeknur
    Civan, Caner
    Ozkan, Zeynep Goezde
    Kuyumcu, Serkan
    Iribas, Ayca
    Sanli, Mehmet Oner
    Sanli, Yasemin
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2021, 84 (01): : 48 - 56
  • [44] PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review
    Lars J. Petersen
    Helle D. Zacho
    Cancer Imaging, 20
  • [45] PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review
    Petersen, Lars J.
    Zacho, Helle D.
    CANCER IMAGING, 2020, 20 (01)
  • [46] Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavorable intermediate and high-risk prostate cancer
    Campana, John
    Bernal, Patricia
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (09) : 2670 - 2671
  • [47] Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavorable intermediate and high-risk prostate cancer
    John Campaña
    Patricia Bernal
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2670 - 2671
  • [48] Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy
    Budaeus, Lars
    Leyh-Bannurah, Sami-Ramzi
    Salomon, Georg
    Michl, Uwe
    Heinzer, Hans
    Huland, Hartwig
    Graefen, Markus
    Steuber, Thomas
    Rosenbaum, Clemens
    EUROPEAN UROLOGY, 2016, 69 (03) : 393 - 396
  • [49] Survival outcomes in men with unfavorable intermediate-risk and high-risk prostate cancer treated with prostate-only versus whole pelvic radiation therapy.
    Andruska, Neal
    Fischer-Valuck, Benjamin Walker
    Diaz, Elizabeth Juarez
    Agabalogun, Temitope
    Brenneman, Randall
    Gay, Hiram Alberto
    Michalski, Jeff M.
    Baumann, Brian C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [50] The emerging role of prostate-specific membrane antigen (PSMA) PET-CT in patients with high-risk prostate cancer: moving the bar in high-risk prostate cancer
    Aragon-Ching, Jeanny B.
    ASIAN JOURNAL OF ANDROLOGY, 2021, 23 (01) : 1 - 2
12345